CS logo
small CS logo
MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C.

Grodzisk Mazowiecki, Poland

About MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C.


During the past decade, MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C." #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "OCT Clinical Trials" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C.


According to Clinical.Site data, the most researched conditions in "MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C." are "Arthritis, Rheumatoid" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C." in a lesser frequency.

Clinical Trials Intervention Types at MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C.


Most popular intervention types in "MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C." are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "BI 695501" (2 trials), "Placebo" (2 trials), "Concomitant treatment" (1 trials), "Linagliptin" (1 trials) and "M2591 25 mg QD" (1 trials). Other intervention names were less common.

Clinical Trials Genders at MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C.


The vast majority of trials in "MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C." are 5 trials for "All" genders.

Clinical Trials Status at MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C.


Currently, there are NaN active trials in "MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C., undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".